Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol)

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 6

Abstract

Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the CBC changes in patients undergoing FAC and AC protocols. Methodology: A comparative retrospective study was performed to determine CBC changes in breast cancer patients following 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and cyclophosphamide (ACProtocol) among 150 breast cancer patients following 4 cycles of respective protocols. Marital status, surgical history, stages, diagnosis and receptor status were also determined. The parameters under observation were hemoglobin, platelets, MCV, MCHC, RBC’s, WBC’s, monocytes, lymphocytes, eosinophils and neutrophils. Data was analyzed using SPSS. Results: FAC and AC protocol influenced the values of CBC in breast cancer patients in different patterns. A mild decrease in the Hemoglobin level and a significant decrease in the value of RBC’s and significant increase in the level of MCV was observed in the study population after 4 cycles of both FAC and AC protocols of chemotherapy where most of the parameters such as platelets, MCV, Monocytes, Neutrophils, Eosinophils, Lymphocytes and WBCs remained in the normal range except hemoglobin, MCHC and RBCs by the end of 4th cycle of the therapy. Conclusion: No significant difference was observed with the CBC changes in both protocols. A frequent investigation of CBC parameters and careful selection of chemotherapy protocol should be done in patients who are prone to CBC disturbances.

Authors and Affiliations

Asif U, Yousaf M, Saleem Z*, Raza SA, Iftikhar N, Ibrahim K, Nasir Z, Saeed A and Bashir A

Keywords

Related Articles

Virtual Screening and Validation of Potential Lead Compound from the Malaria Box against Plasmodium Falciparum S7 and S19 Proteins

Molecular docking is a computer based tool used in drug design, where predominant binding modes of a ligand with known three dimensional protein structures are predicted. This study addresses the possible ways of coming...

Generation (Wh) Y; The Digital Face of Pharmaceutical Education

The undergraduate population in pharmaceutical science is now more diverse than ever before, presenting considerable teaching challenges as educators are faced with increasing student numbers, lack of space availability...

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Moexipril and Hydrochlorothiazide in Bulk and Tablet Dosage Form

A simple, fast, precise reverse phase and isocratic HPLC method was developed for the separation and quantification of Moexipril (MXP) and Hydrochlorothiazide (HCT) in pharmaceutical dosage form. The quantification was c...

Investigation of Phytochemical Profile and Combine Synergistic Anti-Diarrheal Potential of Peperomia Pellucida Aerial Part and Cyprus Esculentus Root Extracts

Peperomia pellucida and Cyperus esculentuslocally found plant used for anti-diarrhoeal activity using standard animal model. The aerial parts of Peperomia pellucidaand Cyperus esculentuswere collected from Trikaripur for...

Quantum Dots: Need to Explore Potential for Delivery of Drugs & Biomolecules

Quantum dots (QDs) are the semiconductor nanoparticles having the range of 2 nm to 10 nm [1]. One of the properties of semiconductor metals of the group IV to group VI of periodic table, to show fluorescence is establis...

Download PDF file
  • EP ID EP745870
  • DOI 10.23880/oajpr-16000131
  • Views 1
  • Downloads 0

How To Cite

Asif U, Yousaf M, Saleem Z*, Raza SA, Iftikhar N, Ibrahim K, Nasir Z, Saeed A and Bashir A (2017). Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol). Open Access Journal of Pharmaceutical Research, 1(6), -. https://europub.co.uk/articles/-A-745870